About this trial
Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. It is now realized that intraoperative hypotension is an important risk factor for the development of AKI. In a recent randomized controlled trial of patients undergoing major noncardiac surgery, intraoperative individualized blood-pressure management reduced the incidence of postoperative organ dysfunction. The investigators hypothesize that, for patients undergoing off-pump CABG, targeted blood-pressure management during surgery may also reduce the incidence of postoperative AKI.
Eligibility criteria
Qualifiers
Age ≥ 50 years;
Scheduled to undergo off-pump CABG surgery.
Disqualifiers
Refuse to participate;
Untreated or uncontrolled severe hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg);
Chronic kidney disease with a glomerular filtration rate < 30 ml/min/1.73 m2 or end-stage renal disease requiring renal-replacement therapy;
Inability to communicate during the preoperative period because of coma, profound dementia, language barrier, or end-stage disease;
Trial design
Treatments tested in this trial
- Targeted blood-pressure management
- Routine blood-pressure management